The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Category: Clinical Trials
-
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The New York Times – Business: -
How Cardiologists’ High Hopes for Two Drugs Were Dashed
The New York Times – Business:By every measure, the drugs were no better than placebos, full data revealed on Saturday. Was it the fault of the design of the studies, or our very hypotheses about heart disease?
-
H.I.V. Research Networks Face Uncertain Future Amid Funding Delays
The New York Times – Business:The networks also study treatments and preventions for other infectious diseases and were instrumental in testing the Covid vaccine.
-
A.I. Agents as ‘Co-Scientists’? This Lab Says They Could Speed Drug Research.
The New York Times – On the Runway:A.I. is already a powerful tool for scientific discovery. Now, some biomedical researchers are teaching it to do even more.
-
The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
The New York Times – Business:Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
-
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
The New York Times – Business:Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates the huge inflation in cancer drug prices over the past two decades.
-
‘Intrinsic Capacity’: The Most Important Longevity Term You’ve Never Heard Of
The New York Times – On the Runway:Intrinsic capacity is quickly becoming a preferred way to measure and assess human aging.
-
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
The New York Times – Business:Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
-
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
The New York Times – Business:In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
-
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
The New York Times – Business:In a notice flagging a series of problems with a clinical trial, the journal Nature Medicine said its editors “no longer have confidence in the integrity of the results.”
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Times – Business:The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
